Search Results - "Graudins, Linda V."

Refine Results
  1. 1

    Off-label use of medicines: consensus recommendations for evaluating appropriateness by Gazarian, Madlen, Kelly, Maria, McPhee, John R, Graudins, Linda V, Ward, Robyn L, Campbell, Terence J

    Published in Medical journal of Australia (20-11-2006)
    “…Off‐label prescribing is the prescription of a registered medicine for a use that is not included in the product information. The practice is common, with…”
    Get full text
    Journal Article Conference Proceeding
  2. 2

    WHO High 5s Project: Medication Reconciliation International Meeting by Graudins, Linda V

    Published in Journal of pharmacy practice and research (01-06-2013)
    “…ABSTRACT Medication reconciliation is in the forefront of medication safety programs, both in Australia due in part to updated accreditation standards, and…”
    Get full text
    Journal Article
  3. 3

    Medication Safety: Experiential Learning for Pharmacy Students and Staff in a Hospital Setting by Graudins, Linda V, Dooley, Michael J

    Published in Pharmacy (17-11-2016)
    “…Medication Safety has been an established pharmacy specialty in Australian hospitals since the early 2000s and is now one of the ten Australian hospital…”
    Get full text
    Journal Article
  4. 4

    Changes in anticonvulsant prescribing for Australian children: Implications for Quality Use of Medicines by Cohen, Simon A, Lawson, John A, Graudins, Linda V, Pearson, Sallie-A, Gazarian, Madlen

    Published in Journal of paediatrics and child health (01-06-2012)
    “…Aims:  The evidence‐base guiding choices between newer versus established anticonvulsants in children is limited. Inappropriate use exposes children to…”
    Get full text
    Journal Article
  5. 5

    Reduction in preventable time-critical dose omissions: impact of electronic medication management systems on in-patients by Graudins, Linda V, Crute, Stephanie, Poole, Susan G, Bingham, Gordon, Dooley, Michael J

    “…: The omission of time-critical medication doses may result in poor patient outcomes. There are few publications about the influence of electronic medication…”
    Get full text
    Journal Article
  6. 6

    Safety of Intravenous Iron Following Infusion Reactions by Stojanovic, Stephanie, Graudins, Linda V., Aung, Ar Kar, Grannell, Louise, Hew, Mark, Zubrinich, Celia

    “…Where an ongoing requirement for intravenous iron replacement exists after an index infusion reaction, current recommendations are limited to expert opinion…”
    Get full text
    Journal Article
  7. 7

    Development and application of Adverse drug reactions reports QUality Algorithm (AQUA-12) score: a single-centre quality improvement initiative by Aung, Ar Kar, Zubrinich, Celia M., Goh, Michelle S. Y., Snyder, Benjamin, Tang, Mei Jie, Khu, Cindy Y. L., Lee, Jennifer I., Graudins, Linda V.

    Published in European journal of clinical pharmacology (01-04-2023)
    “…Purpose To develop a reliable assessment tool to monitor the quality of adverse drug reaction (ADR) reports and evaluate its performance within a quaternary…”
    Get full text
    Journal Article
  8. 8

    Old but not forgotten: Antibiotic allergies in General Medicine (the AGM Study) by Trubiano, Jason A, Pai Mangalore, Rekha, Baey, Yi‐Wei, Le, Duy, Graudins, Linda V, Charles, Patrick GP, Johnson, Douglas F, Aung, Ar Kar

    Published in Medical journal of Australia (18-04-2016)
    “…Objectives: To determine the nature, prevalence and description accuracy of recorded antibiotic allergy labels (AALs) in a cohort of general medical…”
    Get full text
    Journal Article
  9. 9

    Implementing a sustainable medication reconciliation process in Australian hospitals: The World Health Organization High 5s project by Stark, Helen E., Graudins, Linda V., McGuire, Treasure M., Lee, Cathy Yuen Yi, Duguid, Margaret J.

    “…Medication reconciliation (medrec) is a mandated patient safety strategy by national, including Australian, accreditation bodies. Yet there are no validated…”
    Get full text
    Journal Article
  10. 10

    Recommendations and Low-Technology Safety Solutions Following Neuromuscular Blocking Agent Incidents by Graudins, Linda V., Downey, Glenn, Bui, Thuy, Dooley, Michael J.

    “…Neuromuscular blocking agents (NMBs) are high-risk medications used to facilitate endotracheal intubation and artificial ventilation. In an incident at a…”
    Get full text
    Journal Article
  11. 11

    Medication‐related anaphylaxis treated in hospital: Agents implicated, patient outcomes, and management lessons by Graudins, Linda V., Trubiano, Jason A., Zubrinich, Celia M., Elliott, Ainslee S., Aung, Ar Kar

    Published in Pharmacoepidemiology and drug safety (01-09-2018)
    “…Purpose On background of increasing medication‐related anaphylaxis rates in Australia, our aim was to determine epidemiology, outcomes, adverse drug reaction…”
    Get full text
    Journal Article
  12. 12

    Probable fenofibrate-induced acute generalized exanthematous pustulosis by POWER, ANNA E, GRAUDINS, LINDA V, McLEAN, CATRIONA A, HOPPER, INGRID

    Published in American journal of health-system pharmacy (01-12-2015)
    “…PURPOSEThe case of a patient who experienced a severe adverse reaction requiring emergency treatment after a single dose of fenofibrate is described. SUMMARYA…”
    Get full text
    Journal Article
  13. 13

    Drug‐induced liver injury is frequently associated with severe cutaneous adverse drug reactions: experience from two Australian tertiary hospitals by Fang, Wendy C., Adler, Nikki R., Graudins, Linda V., Goldblatt, Caitlin, Goh, Michelle S. Y., Roberts, Stuart K., Trubiano, Jason A., Aung, Ar Kar

    Published in Internal medicine journal (01-05-2018)
    “…Background Drug‐induced liver injury (DILI) can be associated with certain cutaneous adverse drug reaction (cADR). Aims To demonstrate the prevalence of DILI…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Preventing motion sickness in children by Graudins, Linda V

    Published in Australian prescriber (01-06-2009)
    “…Motion sickness is a normal response to abnormal stimuli. The peak incidence occurs in children under 12 years, but it is uncommon in infants. As this…”
    Get full text
    Journal Article
  17. 17

    Pertussis prevention and treatment: a call for wider access to azithromycin by Bowen, Asha C, Ferson, Mark J, Graudins, Linda V, Palasanthiran, Pamela

    Published in Medical journal of Australia (06-04-2009)
    “…Azithromycin is recommended as the first‐line antibiotic for the prophylaxis and treatment of pertussis, a common vaccine‐preventable communicable disease…”
    Get full text
    Journal Article
  18. 18

    Variation in Paediatric Omeprazole Dosing by Graudins, Linda V

    Published in Journal of pharmacy practice and research (01-12-2008)
    “…ABSTRACT Aim To characterise enteral omeprazole prescribing for paediatric inpatients; to compare doses prescribed for tablets and mixtures; and to compare…”
    Get full text
    Journal Article
  19. 19

    Paedpharm: Paediatric Pharmacy Network by Graudins, Linda V, Turner, Sean, Kunac, Desiree

    Published in Journal of pharmacy practice and research (01-12-2009)
    “…ABSTRACT Background Up‐to‐date data on paediatric therapeutics, such as off‐label use of medicines, availability of unlicensed formulations and medication…”
    Get full text
    Journal Article
  20. 20

    Adverse Drug Reactions during Hospital Stay: Evaluation of a Model for Informing Patients by Graudins, Linda V, Hopper, Ingrid, Treseder, Rowena J, Lord, Julie AV, Dooley, Michael J

    Published in Journal of pharmacy practice and research (01-06-2012)
    “…ABSTRACT Background Informing patients about their adverse drug reactions (ADRs) and involving them in their medication management should decrease repeat ADRs…”
    Get full text
    Journal Article